Stockscreener 앱 받기
0.82%
Amgen Inc 주식(AMGN)의 최신 뉴스
Zions Bancorporation National Association UT Sells 10,088 Shares of Amgen Inc. $AMGN - MarketBeat
Vanguard Group Inc. Purchases 165,281 Shares of Amgen Inc. $AMGN - MarketBeat
Public Sector Pension Investment Board Has $13.34 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Holdings Lowered by Fifth Third Bancorp - MarketBeat
Why Amgen Inc. stock is seen as undervaluedWeekly Profit Analysis & Safe Capital Growth Tips - mfd.ru
Shell Asset Management Co. Has $2.82 Million Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Purchased by State of New Jersey Common Pension Fund D - MarketBeat
A Look At Amgen (AMGN) Valuation After Strong Q4 Results And New UPLIZNA Approval - simplywall.st
PNC Financial Services Group Inc. Increases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
HighTower Advisors LLC Grows Position in Amgen Inc. $AMGN - MarketBeat
ABN Amro Investment Solutions Sells 8,219 Shares of Amgen Inc. $AMGN - MarketBeat
Aberdeen Group plc Sells 76,076 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Downgraded to "Hold" Rating by Freedom Capital - MarketBeat
BTC Capital Management Inc. Grows Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Assetmark Inc. Buys 10,886 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Position Lifted by Ameritas Advisory Services LLC - MarketBeat
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight - GuruFocus
Amgen (AMGN) Files for Automatic Mixed Securities Shelf Registra - GuruFocus
AMGEN INC SEC 10-K Report - TradingView
AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT - marketscreener.com
How to watch Amgen at Citi's 2026 virtual oncology summit - Stock Titan
Here's What Argus Research and Guggenheim Are Saying About Amgen Inc. (AMGN) - Bitget
Amgen wins new EU approval for Uplizna in gMG - European Pharmaceutical Review
Here’s what Argus Research and Guggenheim are saying about Amgen Inc. (AMGN) - MSN
Here’s What Argus Research and Guggenheim Are Saying About Amgen Inc. (AMGN) - Yahoo Finance
Amgen wins European approval to challenge argenx and UCB for autoimmune market - European Biotechnology Magazine
Amgen Inc. $AMGN Shares Sold by Savvy Advisors Inc. - MarketBeat
LSV Asset Management Raises Holdings in Amgen Inc. $AMGN - MarketBeat
Krilogy Financial LLC Takes $1.25 Million Position in Amgen Inc. $AMGN - MarketBeat
Baader Bank Aktiengesellschaft Lowers Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stake Lessened by Atria Investments Inc - MarketBeat
UPLIZNA’s Expanded EU Use in Autoimmune Disease Could Be A Game Changer For Amgen (AMGN) - simplywall.st
Amgen Conference: UPLIZNA Phase III Plans, Daxdilimab Lupus Data, and TEZSPIRE Expansion Update - MarketBeat
AMGN: Advancing late-stage trials and expanding TSLP-targeted therapies, with major data readouts ahead - TradingView
Traders Buy Large Volume of Amgen Call Options (NASDAQ:AMGN) - MarketBeat
Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.52 - Yahoo Finance
Amgen wins EC approval for Uplizna in gMG - The Pharma Letter
Amgen wins EC approval for Uplinza in gMG - The Pharma Letter
Can Amgen Inc. reach all time highs this yearQuarterly Profit Summary & Long-Term Growth Portfolio Plans - mfd.ru
Varma Mutual Pension Insurance Co Buys 7,300 Shares of Amgen Inc. $AMGN - MarketBeat
EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS - PR Newswire
Leuthold Group LLC Purchases New Stake in Amgen Inc. $AMGN - MarketBeat
Stratos Wealth Partners LTD. Has $8.83 Million Stake in Amgen Inc. $AMGN - MarketBeat
Cibc World Market Inc. Grows Stake in Amgen Inc. $AMGN - MarketBeat
ABC Arbitrage SA Cuts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Ex-Dividend Reminder: Cencora, Amgen and Oppenheimer Holdings - Nasdaq
Amgen (NASDAQ:AMGN) Price Target Raised to $295.00 - MarketBeat
Rhumbline Advisers Sells 6,685 Shares of Amgen Inc. $AMGN - MarketBeat
Prospera Financial Services Inc Sells 6,723 Shares of Amgen Inc. $AMGN - MarketBeat
Caprock Group LLC Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Wealthfront Advisers LLC Grows Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Holdings Reduced by Allegheny Financial Group - MarketBeat
How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - Stock Traders Daily
AstraZeneca Unit Settles Soliris Feud With Samsung, Amgen - Law360
Mizuho Raises Price Target on Amgen to $295 From $280, Keeps Outperform Rating - marketscreener.com
Daiwa Securities Group Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - MarketBeat
Just Two Days Till Amgen Inc. (NASDAQ:AMGN) Will Be Trading Ex-Dividend - 富途牛牛
United States Biotechnology Market to hit US$ 1.5 Trillion - openPR.com
Two Days Left Until Amgen Inc. (NASDAQ:AMGN) Trades Ex-Dividend - simplywall.st
Daiwa Securities Adjusts Price Target on Amgen to $410 From $370, Maintains Outperform Rating - marketscreener.com
The 5 Most Interesting Analyst Questions From Amgen's Q4 Earnings Call - Finviz
The 5 Most Interesting Analyst Questions From Amgen’s Q4 Earnings Call - The Globe and Mail
Alps Advisors Inc. Has $5.29 Million Stake in Amgen Inc. $AMGN - MarketBeat
Wesbanco Bank Inc. Increases Stake in Amgen Inc. $AMGN - MarketBeat
First National Trust Co Trims Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Amgen stands by vasculitis drug Tavneos after FDA wants it pulled - ANCA Vasculitis News
When Advocacy Meets Science in the Care of People Living with gMG - Amgen
2.09%
자본화:
|
볼륨(24시간):